Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S3A pseudogene 32 (RPS3AP32) is a processed pseudogene, also called a retrocopy, originating from the parental functional gene RPS3A, which encodes a protein component of the small (40S) ribosomal subunit. RPS3AP32 is located on chromosome 10:106,266,076-106,266,318 (according to RCPedia)[6], or chromosome 8:74,055,882-74,056,647 (Ensembl)[8]. As a pseudogene, RPS3AP32 does not encode a functional protein, and there is no evidence for transcriptional or regulatory activity for this locus. Pseudogenes rarely contribute to cellular phenotypes unless acting via regulatory noncoding RNAs, which is not indicated for RPS3AP32. There are no known disease associations, clinical uses, or drugs targeting RPS3AP32.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 32 (RPS3AP32).